# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!


B-Cell Lymphomas

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 521-530 of 581 results.
Efficacy and Safety of Chi-BEAC Combining With Auto-HSCT to Treat Aggressive Lymphoma Subjects
Status: Recruiting
Last Changed: Jan 15, 2019
First Received: Aug 14, 2018
Disease(s): Lymphoma, Large B-Cell, Diffuse, Mantle Cell Lymphoma, Peripheral T Cell Lymphoma, Double-hit Lymphoma
Intervention(s): Chidamide
Locations: Hematological Department, People's Hospital of Jiangsu Province, Nanjing, Jiangsu, China
T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas
Status: Recruiting
Last Changed: Oct 23, 2020
First Received: Feb 10, 2017
Disease(s): Lymphoma, Large-Cell, Anaplasitc, Enteropathy-Associated T-Cell Lymphoma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Extranodal NK-T-Cell, Lymphoma, T-Cell, Peripheral
Intervention(s): Anti-CD30-CAR T cells, Cyclophosphamide, Fludarabine
Locations: National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Auto Stem Cell Transplant for Lymphoma Patients
Status: Recruiting
Last Changed: Oct 01, 2020
First Received: Apr 24, 2017
Disease(s): Non-Hodgkin Lymphoma, Hodgkin Lymphoma
Intervention(s): Etoposide, BCNU, AraC, Melphalan, Peripheral blood stem cell transplantation, G-CSF, Cyclophosphamide, Total Body Irradiation
Locations: Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
Ibrutinib + R-CHOP Followed by Ibrutinib Maintenance
Status: Recruiting
Last Changed: May 18, 2020
First Received: Nov 06, 2018
Disease(s): DLBCL
Intervention(s): Ibrutinib
Locations: A.O. SS. Antonio e Biagio e Cesare Arrigo - S.C. Ematologia, Alessandria, Italy
Università Politecnica delle Marche- Clinica di Ematologia, Ancona, Italy
Centro Riferimento Oncologico- S.O.C. Oncologia Medica A, Aviano, Italy
IRCCS Istituto Tumori Giovanni Paolo II - U.O.C Ematologia, Bari, Italy
Policlinico S.Orsola-Malpighi - Istituto di Ematologia "Seragnoli", Bologna, Italy
... and 39 other locations.
Sintilimab in Combination With R-CHOP in Patients With Treatment-naive EBV-positive DLBCL, NOS
Status: Recruiting
Last Changed: Nov 29, 2019
First Received: Nov 29, 2019
Disease(s): EBV-Positive DLBCL, Nos
Intervention(s): Sintilimab, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisolone
Locations: ChangZhou First People's Hospital, ChangZhou, Jiangsu, China
ChangZhou No.2 People's Hospital, ChangZhou, Jiangsu, China
HuaiAn First People's Hospital, HuaiAn, Jiangsu, China
Drum tower hospital, Nanjing, Jiangsu, China
The first Affiliated Hospital Of Nanjing Medical University(JiangSu Province Hospital), NanJing, Jiangsu, China
... and 7 other locations.
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Status: Recruiting
Last Changed: Feb 12, 2019
First Received: Jul 08, 2009
Disease(s): Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Unspecified Adult Solid Tumor, Protocol Specific
Intervention(s): 3'-deoxy-3'-[18F]fluorothymidine
Locations: Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States
Lenalidomide in Combination With R-DA-EPOCH in Patients With Untreated DLBCL With MYC Rearrangement
Status: Recruiting
Last Changed: Jun 16, 2020
First Received: Jun 16, 2020
Disease(s): DLBCL, Untreated, MYC Gene Rearrangement
Intervention(s): Lenalidomide, Rituximab, Etoposide, Doxorubicin, Vincristine, Cyclophosphamide, Prednisone
Locations: The first Affiliated Hospital Of Nanjing Medical University(JiangSu Province Hospital), Nanjing, Jiangsu, China
Recommendations for the Treatment of Children With Burkitt's Lymphoma
Status: Not yet recruiting
Last Changed: Jun 18, 2020
First Received: Jun 11, 2020
Disease(s): Burkitt Lymphoma
Intervention(s): OBSERVATIONAL
Locations: CHU de Treichville à ABIDJAN, Abidjan, Côte D'Ivoire
Clinical Factors and Gene Expression Analysis for Prognosis in Tissue Samples From Patients With AIDS-Related Primary Effusion Lymphoma
Status: Recruiting
Last Changed: Oct 24, 2019
First Received: Jul 06, 2016
Disease(s): AIDS-Related Primary Effusion Lymphoma
Intervention(s): Laboratory Biomarker Analysis, Medical Chart Review
Locations: UC San Diego Moores Cancer Center, La Jolla, California, United States
UCLA CARE Center, Los Angeles, California, United States
University of Miami, Miami, Florida, United States
Stroger Hospital of Cook County, Chicago, Illinois, United States
Virginia Mason Medical Center, Seattle, Washington, United States
... and 1 other locations.
REal World Data in LYmphoma and Survival in Adults
Status: Recruiting
Last Changed: Mar 11, 2019
First Received: Mar 11, 2019
Disease(s): Diffuse Large B Lymphoma (DLBCL), Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL), Marginal Zone Lymphoma (MZL), T-cell Lymphoma (T-NHL), Hodgkin's Lymphoma (HL), Burkitt Lymphoma (BL))
Intervention(s): Real-life epidemiological platform of lymphoma in France
Locations: Institut Bergonié, Bordeaux, France
CHU Francois MITTERRAND, Dijon, France
CHD Vendée, La Roche-sur-Yon, France
CHU Haut-Lévêque, Pessac, France
Centre Hospitalier Lyon Sud, Pierre-Bénite, France
... and 3 other locations.